ALDH2 and triple-A syndrome: Herein, we aimed to decipher the effect of endothelial barrier defect during early‐stage AAA and whether it is subject to ALDH2 regulation to pinpoint potential modulators of endothelial barrier function as therapeutic targets for early‐stage AAA.